SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-039196
Filing Date
2023-08-11
Accepted
2023-08-11 08:51:01
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20057115_10q.htm   iXBRL 10-Q 1334096
2 EXHIBIT 10.3 brhc20057115_ex10-3.htm EX-10.3 64137
3 EXHIBIT 31.1 brhc20057115_ex31-1.htm EX-31.1 8242
4 EXHIBIT 31.2 brhc20057115_ex31-2.htm EX-31.2 8189
5 EXHIBIT 32.1 brhc20057115_ex32-1.htm EX-32.1 5750
  Complete submission text file 0001140361-23-039196.txt   6652329

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocup-20230630.xsd EX-101.SCH 59676
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocup-20230630_cal.xml EX-101.CAL 35100
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocup-20230630_def.xml EX-101.DEF 274785
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20230630_lab.xml EX-101.LAB 653643
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20230630_pre.xml EX-101.PRE 410683
68 EXTRACTED XBRL INSTANCE DOCUMENT brhc20057115_10q_htm.xml XML 929748
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 231161701
SIC: 2834 Pharmaceutical Preparations